Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19

News

Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19

13.08.2020 News

Johnson & Johnson was one of the first companies to devote large resources to the fight against COVID-19 and vaccine development, and was one of the first to receive support from the US government.

However, J&J is not currently one of the companies, who conducting clinical trials of its final vaccine candidates COVID-19 in humans. Among others, the leaders are now companies such as Pfizer and BioNTech, Moderna.

However, J&J is the world’s largest medical company with a huge resource, and its candidate for the COVID-19 vaccine, according to current data, has more privileges that can make it the biggest winner of all.

Johnson & Johnson may offer only one dose for strong immunity

J&J published on July 30 the results of a preclinical study of the leading candidate for the vaccine “Ad26.COV2-S”, on primates, they showed the formation of strong immune responses from the viral growths of high levels of neutralizing antibodies, which can be infected with coronavirus.

Particularly optimistic is that a strong immune suppressor primates took after a single dose of vaccine. although the company plans to include both single and double dosing in their planned studies in humans, chances are that it can confirm the effectiveness of a single injection of the vaccine. Potentially it may be cheaper and acceptable for government vaccination programs.

In addition to more potential priority of a single-dose approach, J&J also intends to charge a much lower fee for the vaccine than its main competitors.

Last week, J&J signed a deal with the US government to supply 100 million doses of Ad26.COV2-S for about $ 1 billion. By comparison, Pfizer and BioNTech will ship 100 million doses to the United States almost twice as expensive – $ 1.9 billion.

Lower prices with fewer doses may seem like an unwise strategy, however, experts are asking investors not to “write off J&J from the accounts” because, according to epidemiologists, COVID-19 can still “live” on our land for a long time. There is a high probability that vaccination against COVID-19 may be the same procedure as the traditional annual vaccination against influenza.

In the current environment, while continuing pandemic, J & J, probably will sell it at cost. A disposable, inexpensive vaccine from a world-renowned company can be very attractive to governments around the world. This can create good publicity for the vaccine and the potential for sales at a higher price later when added to the traditional annual vaccination calendar.

Investors will learn more about Johnson & Johnson’s Ad26.COV2-S vaccine in September, when the company moves to a later stage of the study.

Other articles

  • The first batch of Pfizer COVID vaccine has arrived in Israel
    News

    The first batch of Pfizer COVID vaccine has arrived in Israel

    The first batch of Pfizer coronavirus vaccine has been delivered to Israel. This was reported by The Jerusalem Post on Wednesday, December 9. “A DHL flight from Brussels carried more than 100,000 doses of the newly created vaccine and landed at Ben Gurion Airport in Tel Aviv around 9 a.m.,” the statement said. The doses […]

  • Pfizer will deliver half of the planned number of vaccines in 2020
    News

    Pfizer will deliver half of the planned number of vaccines in 2020

    Shares of Pfizer and BioNTech fell 1.74% and 2% (respectively) on Thursday amid news that companies will deliver half of their planned number of vaccines against COVID-19 in 2020. On November 20, Pfizer and its German partner BioNTech applied to the FDA (US Food and Drug Administration) for permission to use their vaccine in an […]

  • US pharmaceutical giant Pfizer will open a new hub in Greece
    News

    US pharmaceutical giant Pfizer will open a new hub in Greece

    American Pfizer is one of the world’s largest pharmaceutical companies. Greek government spokesman Stelios Petsas stated it’s expanding its presence in Greece, creating 600 workplaces. Pfizer’s chairman is Greek Albert Burla. In recent months, the company has been developing a vaccine against coronavirus. A company hub opens in Thessaloniki. “Greece is attracting big investment and […]

  • Gucci to donate half a million dollars to UNICEF for vaccination against COVID-19
    News

    Gucci to donate half a million dollars to UNICEF for vaccination against COVID-19

    The most popular fashion brand Gucci will donate about $ 500,000 for the purchase and distribution of a new type of coronavirus vaccine among vulnerable people around the world. It is noted that the funds will be transferred to UNICEF, which supports the WHO initiative on mass vaccination COVAX and the GAVI group. “Global equitable […]

  • Lufthansa has announced large-scale job-cuts
    News

    Lufthansa has announced large-scale job-cuts

    By the end of this year, the German airline Lufthansa intends to reduce its foreign staff by 20 thousand people, as well as sell its LSG division, which deals with on-board catering, which employs 7.5 thousand people. Lufthansa subsidiaries Eurowings, Swiss, Austrian and Brussels Airlines are reducing the frequency of flights, fleets and staff amid […]

  • Johnson & Johnson plans to complete the third phase of trials of the COVID-19 vaccine in January
    News

    Johnson & Johnson plans to complete the third phase of trials of the COVID-19 vaccine in January

    Johnson & Johnson plans to complete the third phase of trials of its single-dose vaccine against COVID-19 in mid-January 2021. Paul Stoffels, vice chairman of the executive committee, senior scientific expert at Johnson & Johnson said they plan to deliver to market 1 billion doses. “We are in the middle of the third phase of […]

  • Moderna vaccine will be tested on teenagers
    News

    Moderna vaccine will be tested on teenagers

    The mRNA-1273 vaccine from the American company Moderna will be tested on three thousand children in six US states. CNN reported this on Wednesday, December 2. “Moderna has started inviting children over the age of 12 to try the vaccine” the statement said. It is noted that the study will involve volunteers aged 12-18 from […]

  • Moderna has reported 100% efficiency of the vaccine against severe cases of COVID-19
    News

    Moderna has reported 100% efficiency of the vaccine against severe cases of COVID-19

    Following the third phase of trials of its COVID-19 coronavirus vaccine, Moderna said the drug was generally well tolerated and no serious health problems were identified. According to the company, the effectiveness of its vaccine reaches 94.1%, and 100% for preventing severe coronavirus cases. Previously, the manufacturer estimated the effectiveness of its drug at 94.5%. […]

Read also

Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Berkshire Hathaway is investing $ 570 million in technology startup of the Snowflake

Warren Buffett’s US company – Berkshire Hathaway intends to invest more than $ 570 million in Snowflake, a cloud technology company. It was reported after Snowflake announced a price range for its future initial public offering. The company wants to get the estimate of $ 23.7 billion, writes the Financial Times. Snowflake said that during […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Nomura Holdings buys 41% stake in American Century Investments for $ 1 billion

Many  large Japanese companies continue to expand  their presence in the international financial sector, they invest  to promising companies. Major Japanese financial  company Nomura Holdings acquires from Canadian Imperial Bank 41% stake  of the US investment company American Century Investments. Canadian Imperial Bank acquired this piece at American Century Investments in 2011 for $ 848 […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Coca-Cola’s net profit for 9 months decreased by 9%

The net profit of the world’s largest producer of soft drinks Coca-Cola, which falls on the company’s shareholders, in the first nine months of the year decreased by 9% year on year and amounted to 6.291 billion dollars, according to company reports. Adjusted earnings per share were $ 1.46 against $ 1.6 a year earlier. […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Souce business: what is happening with the production in Ukraine?

In Ukraine it is observed the decline in the production of sauces , namely the manufacture of ketchup, sauces based on mayonnaise and mustard. But, nevertheless, the export of these products was reduced insignificantly by manufacturers and domestic demand continues to be satisfactory. According to the State Statistics Service of Ukraine, figure of ketchup manufacturing […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
Analytics

Unlike Sweden which recycles more than 99% of its waste, Ukraine is suffering from rubbish

Only recently, people around the world began to realize that used things accumulated in landfills are not stored there for free. Those who drink dirty water, breathe dirty air suffer from that. People have to see an unpleasant sight and beware of pollution of the surrounding areas… However, this problem can be turned into money, […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Experts predict a low oil price in September

The price of oil in September will remain low, perhaps even a slight decrease from current levels below $ 40 per barrel. In October, the downward trend is likely to be interrupted and a gradual growth will begin, which will accelerate in November and December, according to TASS experts. “There will be no serious drop […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Myronivsky Hliboproduct has agreed with the creditors

Eurobond holders of the agricultural holding Myronivsky Hliboproduct  (MHP) for $ 750 million with a circulation period to 2020 agreed to soften some of the conditions of securities’ circulation. According to the Interfax-Ukraine, they agreed to change the definition of “consolidated net income” to exclude the impact of exchange rate differences during any period starting […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Apple Smart Glasses May Appear in the Next 3 Years

Back in 2016, Apple CEO Tim Cook called augmented reality (AR) a “new big market” comparing its size to the smartphone market. According to most analysts, Apple smart glasses will be a new wearable device sold as an additional gadget to the iPhone. Apple itself does not give any details or disclose plans about its […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Pfizer has merged with Allergan to avoid the “non-competitive tax rates.”

A few days ago between two companies was signed an agreement for $ 150 billion. It was the merger of two large companies – manufacturer of drugs and vaccines Pfizer and Allergan, which producing cosmetics and botox. The deal was struck not only to consolidate or improve its production system. The main reason for the […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Bayer sells the part of its business

Bayer AG  is going to sell the part of its business  in biotechnologies and productions of cotton  spheres. It is concerned the Crop Science  subsidiary Company. According to Liman Kondon, the company chairman, this industry sphere is money-making.  There is no reason in  finding buyers  to Buyer. The decision was concluded by a pressure of […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Uber reported a drop in the number of trips, but doubling food delivery orders Eats

Shares of Uber, which rose on 16.7% since the beginning of the year, fell 2.65% after the close of trading on Thursday, in response to the results of the second quarter. Uber management called the quarter “the hardest in history”, given the sharp drop in passenger traffic due to the COVID-19 pandemic. At the same […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Business took eight billion of the available loans

Ukrainian banks have already issued UAH 8 billion in available loans under the “5-7-9” program. This was announced by Finance Minister Serhiy Marchenko on the talk show “Freedom of Speech of Savik Shuster”. “Today, 80 coins from the hryvnia loans are provided under the program of ” 5-7-9 “. UAH 8 billion and 3,000 loans […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Bill Gates has invested nearly $ 80 million in the developer of satellite dishes

The American satellite company Kymeta announced the attraction of $ 85.2 million in the last round of financing. The round was led by Microsoft founder Bill Gates, who invested $ 78.5 million in the startup. Kymeta develops and manufactures high-speed satellite systems and antennas. The main product of the company is a flat satellite antenna […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

The losses of Ukrainian farmers due to the drought were estimated at 118 billion

Ukrainian farmers may lose up to 118 billion hryvnias this year due to drought and frost. This was reported by the press service of the Agrarian Union of Ukraine. “This year, even the critically affected regions (Odessa, Mykolaiv, Kherson, Zaporizhia regions), despite the promises of the state, did not receive a single penny of assistance,” […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Johnson & Johnson suspends the study of the COVID-19 vaccine due to unexplained disease in the participant

Shares of the Johnson & Johnson may slow because the last stimulus to it was the company’s transition to the final clinical trial of the vaccine against COVID-19 on September 23, after which the shares rose by more than 5%. However, as of Tuesday, before the opening of trading, the price of J&J shares did […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Shares of the Bed Bath & Beyond jumped to 33% due to the strong report

Quotes of the Bed Bath & Beyond jumped from 33.47% to $ 19.99 according to the trading data. Papers are growing due to the strong report for the second quarter of 2020. The Bed Bath & Beyond chain announced the first increase in the in-store sales in almost four years. The jump in the revenue […]

Next
WP2Social Auto Publish Powered By : XYZScripts.com